Theravance Biopharma (TBPH) Selling, General & Administrative (2013 - 2026)
Theravance Biopharma's Selling, General & Administrative was $14.18 million in Q2 2026, down 23.1% from $18.43 million a year earlier and down 20.0% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Selling, General & Administrative (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Theravance Biopharma's Selling, General & Administrative was $68.75 million through Jun 30, 2026, down 4.7% year-over-year; for FY2025, it was $73.65 million, up 6.5% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of -7.5% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $69.17 million in FY2024 (-1.3%), $70.1 million in FY2023 (+4.5%), $67.07 million in FY2022 (-32.5%) and $99.3 million in FY2021 (-8.5%).
- The Q2 2026 figure marks the lowest quarterly Selling, General & Administrative since Q2 2014.
- Compared with a year earlier, Selling, General & Administrative was higher in six of the last eight quarters, with growth averaging 3.0%.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2024 (growth of 19.4%); the worst was Q1 2022 (a decline of 41.6%).
- Per Business Quant data, TBPH's Selling, General & Administrative in the three quarters before Q2 2026 was $17.72 million (Q1 2026), $18.52 million (Q4 2025) and $18.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | 14.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.18 Mn |
| Mar 31, 2026 | 17.72 Mn |
| Dec 31, 2025 | 18.52 Mn |
| Sep 30, 2025 | 18.33 Mn |
| Jun 30, 2025 | 18.43 Mn |
| Mar 31, 2025 | 18.37 Mn |
| Dec 31, 2024 | 18.50 Mn |
| Sep 30, 2024 | 16.88 Mn |
| Jun 30, 2024 | 17.06 Mn |
| Mar 31, 2024 | 16.74 Mn |
| Dec 31, 2023 | 15.49 Mn |
| Sep 30, 2023 | 16.14 Mn |
| Jun 30, 2023 | 19.28 Mn |
| Mar 31, 2023 | 19.18 Mn |
| Dec 31, 2022 | 16.73 Mn |
| Sep 30, 2022 | 16.28 Mn |
| Jun 30, 2022 | 16.22 Mn |
| Mar 31, 2022 | 17.84 Mn |
| Dec 31, 2021 | 21.52 Mn |
| Sep 30, 2021 | 21.30 Mn |
API Access
Theravance Biopharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();